Fertility and progeny

European Journal of Cancer

Volumn 38, Issue 12, 2002, Pages 1634-1644

  Thomson, A B ^a   Critchley, H O D ^a   Wallace, W H B ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MELPHALAN; NITROSOUREA DERIVATIVE; PLATINUM DERIVATIVE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE SULFATE;

BIOAVAILABILITY; CHILDHOOD CANCER; FERTILITY; HODGKIN DISEASE; HUMAN; PRIORITY JOURNAL; PROGENY; REVIEW;

EID: 0036342420     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00093-X     Document Type: Article

References (119)

1. Growth and endocrine function following the treatment of childhood malignant disease
2. The impact of childhood cancer on the United States and the world
3. Developing strategies for long term follow up of survivors of childhood cancer
4. Male germ cell transplantation: An experimental approach with a clinical perspective
5. Spermatogenesis following male germ-cell transplantation
6. Rat spermatogenesis in mouse testis
7. Reconstitution of spermatogenesis from frozen spermatogonial stem cells
8. The cryopreservation of ovarian tissue as a strategy for preserving the fertility of cancer patients
9. Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue
10. Ovarian cryopreservation and transplantation: Basic aspects
11. Subfertility following treatment for childhood cancer
12. Gonadal function following chemotherapy for childhood Hodgkin's disease
13. Gonadal function in young patients successfully treated for Hodgkin's disease
14. Gonadal function after combination chemotherapy for Hodgkin's disease in childhood
15. Gonadal damage from chemotherapy and radiotherapy
16. Azoospermia following lower truncal irradiation in Hodgkin's disease
17. Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis
18. Ovarian failure following abdominal irradiation in childhood: The radiosensitivity of the human oocyte
19. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia
20. Male fertility in long-term survivors of acute lymphoblastic leukaemia in childhood
21. Gonadal dysfunction due to cis-platinum
22. Long-term effects of cyclophosphamide on testicular function
23. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease
24. Gonadal toxicity after combination chemotherapy for Hodgkin's disease: Comparative results of MOPP vs ABVD
25. Recovery of spermatogenesis after treatment for Hodgkin's disease: Limiting dose of MOPP chemotherapy
26. Impact of cyclophosphamide and long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas
27. Testicular histology after combination chemotherapy for acute lymphoblastic leukaemia
28. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma
29. The effect of testicular X-irradiation on spermatogenesis in man. A comparison with the mouse
30. Effects of graded ionising radiation on the human testis
31. Vulnerability of the human Leydig cell to radiation damage is dependent upon age
32. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease
33. Cytotoxic induced ovarian failure in women treated for Hodgkin's disease: A comparative study of MVPP and a seven-drug hybrid regimen
34. Gonadal function in Hodgkin's disease: Long-term follow-up of chemotherapy
35. Cytotoxic-induced ovarian failure in women treated with MOPP chemotherapy for Hodgkin's disease
36. Early menopause in long-term survivors of cancer during adolescence
37. Effects of childhood leukaemia and chemotherapy on puberty and reproductive function in girls
38. Evaluation of gonadal function following long-term treatment for acute lymphoblastic leukaemia in girls
39. Pregnancy outcome after treatment for acute lymphoblastic leukaemia during childhood or adolescence
40. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia
41. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia
42. Ovarian failure following marrow transplantation for aplastic anaemia or leukaemia
43. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation
44. Abdominal irradiation in childhood; The potential for pregnancy
45. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: Response to sex steroid replacement
46. Ultrasound B-mode changes in the uterus and ovaries and doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood
47. Oocyte donation in women cured of cancer with bone marrow transplantation including total body irradiation in adolescence
48. Pregnancy outcome after treatment for cute lymphoblastic leukaemia during childhood or adolescence
49. Experience with a 'physiological' steroid replacement regimen for the establishment of a receptive endometrium in women with premature ovarian failure
50. Fertility and pregnancy after treatment for cancer during childhood or adolescence
51. Restoration of fertility to oopherectomized sheep by ovarian autografts stored at -196°C
52. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma
53. Viable embryos from injection of round spermatids into oocytes
54. Human fertilisation with round and elongated spermatids
55. Successful pregnancy after spermatid injection
56. Personal practice: Fertility preservation for children treated for cancer (2): Ethics of consent for gamete storage and experimentation
57. Conference consensus statement: Ethical and research dilemmas for fertility preservation in children treated for cancer
58. Semen cryobanking for men with cancer - Criteria change
59. Semen cryobanking for men with cancer
60. Fertilization and pregnancy rates after intracytoplasmic sperm injection using ejaculate semen and surgically retrieved sperm
61. The relationship of gonadal activity and chemotherapy-induced gonadal damage
62. Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen
63. Protection from radiation-induced damage to spermatogenesis by hormone treatment
64. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration
65. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotrophin-releasing hormone agonist
66. Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat
67. Hormonal protection from cyclophosphamide-induced inactivation of rat stem spermatogonia
68. Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia
69. Use of testosterone to prevent cyclophosphamide-induced azoospermia
70. Effect of luteinizing hormone releasing hormone agonist given during combination chemotherapy on post therapy fertility in male patients with lymphoma: Preliminary observations
71. Failure to preserve fertility in patients with Hodgkin's disease
72. Investigation of temporary suppression of the hypothalamic-pituitary-gonadal axis to enhance recovery of spermatogenesis following cancer therapy in childhood
73. Culture of mouse spermatogonial stem cells
74. Restoration of fertility by in-vitro spermatogenesis
75. In vitro culture facilitates the selection of healthy spermatids for assisted reproduction
76. Germline transmission of donor haplotype following spermatogonial transplantation
77. Germ cell transfer into rat, bovine, monkey and human testes
78. A new technique to protect ovarian function in young women undergoing pelvic irradiation. Heterotopic ovarian autotransplantation
79. Reproductive and endocrine function in patients with Hodgkin's disease: Effects of oopheropexy and irradiation
80. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes
81. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide induced ovarian follicular depletion in Rhesus monkeys
82. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
83. Impact of congenital and experimental hypogonadism on the radiation sensitivity of the mouse ovary
84. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy
85. Preservation of fertility in women undergoing chemotherapy: Current approach and future prospects
86. Restitution of fertility in sterilised mice by transferring primordial ovarian follicles
87. Transplantation of frozen-thawed mouse primordial follicles
88. Live births with autologous transplant of cryopreserved mouse ovaries
89. Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice
90. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients
91. Ovarian banking for cancer patients-transmission of malignant cells in ovarian grafts
92. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro
93. Nouse oocytes derived from in vitro grown primary ovarian follicles are fertile
94. Isolation and long term culture of human preantral follicles
95. Mechanical isolation and in vitro growth of preantral and small antral human follicles
96. Cryopreservation of human ovarian tissue by using dimethylsulphoxide and propandiol-sucrose as cryoprotectants
97. Development in vitro of mouse oocytes from primordial follicles
98. Quantitative study of the development of isolated mouse pre-antral follicles in collagen gel culture
99. Transplantation of cryopreserved fetal ovarian tissue to adult recipients in mice
100. Transplantation in reproductive medicine: Previous experience, present knowledge and future prospects
101. Follicular development from ovarian xenografts in SCID mice
102. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone
103. Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation
104. Cancer among 1348 survivors of childhood cancer
105. Offspring of patients treated for cancer in childhood
106. Detection of deoxyribonucleic acid fragmentation in human sperm: Correlation with fertilization in vitro
107. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility
108. Paternal cyclophosphamide exposure causes decreased cell proliferation in cleavage-stage embryos
109. Sperm chromatin damage impairs human fertility
110. Oxidative damage to DNA in human spermatozoa does not preclude pronucleus formation at ICSI
111. Seven years of intracytoplasmic sperm injection and follow-up of 1987 subsequent children
112. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer
113. Calcium response of human oocytes after intracytoplasmic injection of leukocytes, spermatocytes and round spermatids
114. Nucleic acid synthesis and development of human male pronucleus
115. Genomic imprinting: Review and relevance to human diseases
116. Fertility preservation for children treated for cancer (1): Scientific advances and research dilemmas
117. Pregnancy outcome and offspring after childhood cancer